• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Bio-Rad Laboratories

Abbott alleges former employee took COVID-19-related trade secrets

November 3, 2020 By Brian Buntz

Abbott (NYSE:ABT) has obtained a temporary restraining order against a former marketing executive. The company alleges the former employee stole trade secrets, including details of upcoming COVID-19 products, before accepting a role at a competitor. Virginia Kendall, a U.S. District Judge for the Northern District of Illinois, decided to grant the two-week restraining order against Jerome […]

Filed Under: Diagnostics, Featured, Legal News Tagged With: Abbott Laboratories, Bio-Rad, Bio-Rad Laboratories, coronavirus, COVID-19

Bio-Rad Laboratories appoints new head of clinical diagnostics group

January 7, 2020 By Sean Whooley

Research and clinical diagnostics company Bio-Rad Laboratories (NYSE:BIO) announced that it has appointed Dara Grantham Wright as its executive VP and president of the clinical diagnostics group in a move made effective on Jan. 1. Grantham Wright is taking over for John Hertia, who retired from the position on Dec. 31, 2019. Her responsibilities include providing […]

Filed Under: Business/Financial News, Diagnostics Tagged With: Bio-Rad, Bio-Rad Laboratories, Personnel Moves

Bio-Rad recovering from ransomware attack

December 13, 2019 By Nancy Crotti

Bio-Rad Laboratories (NYSE:BIO) said late Friday afternoon that it is making good progress recovering from a ransomware attack that was detected on the company’s network on December 5. The company did not reveal the hacker’s demands, if any. Once the malicious software was detected, Bio-Rad immediately took certain systems offline, the company said in a […]

Filed Under: Business/Financial News, Featured, Health Technology, Software / IT, Wall Street Beat Tagged With: Bio-Rad Laboratories, cyberattack, Securities & Exchange Commission (SEC)

Bio-Rad whistleblower case heads back to court on appeal

February 27, 2019 By Nancy Crotti

A federal appeals court panel dealt the former general counsel for Bio-Rad Laboratories (NYSE:BIO) a blow, slicing his $11 million jury award by $6 million and sending his whistleblower retaliation lawsuit back to U.S. District Court for a possible new trial. The three-judge panel sitting in San Francisco ruled that the U.S. District Court judge in […]

Filed Under: Business/Financial News, Legal News Tagged With: Bio-Rad Laboratories

Bio-Rad, UChicago win $24m in patent infringement case

November 15, 2018 By Fink Densford

Bio-Rad Laboratories (NYSE:BIO) this week touted a joint legal victory with the University of Chicago in a US Federal District court against rival 10X Genomics, saying that it was awarded $23.9 million in damages in a patent infringement case. The jury in the trial unanimously found that 10X Genomics willfully infringed on Bio-Rad and Univ. of Chicago […]

Filed Under: Legal News, Patent Infringement Tagged With: Bio-Rad Laboratories

Bio-Rad to pony up $3.5m for ex-GC’s legal fees; misses on Q4 earnings

February 24, 2017 By Sarah Faulkner

Bio-Rad Laboratories (NYSE:BIO) agreed to pay $3.5 million in legal fees for the team that represented former general counsel, Sanford Wadler, during a whistleblower retaliation lawsuit Wadler brought against his former employer. The company said it plans to cover “reasonable” attorney fees and expert witness fees and costs, according to an order signed by U.S. […]

Filed Under: Legal News, MassDevice Earnings Roundup Tagged With: Bio-Rad Laboratories

Patent board invalidates RainDance patent for obviousness

January 20, 2017 By Sarah Faulkner

The Patent Trial and Appeal Board invalidated a RainDance Technologies patent earlier this week for obviousness. The patent, which covers a method for manipulating the size of liquid droplets used in microfluidic diagnostic tests, was challenged by manufacturer 10X Genomics Inc. The panel, after conducting an inter partes review, found that the technique’s characteristics, which […]

Filed Under: Diagnostics, Legal News, Wall Street Beat Tagged With: Bio-Rad Laboratories, RainDance Technologies

Bio-Rad Laboratories to acquire RainDance Technologies

January 17, 2017 By Sarah Faulkner

Bio-Rad Laboratories (NYSE:BIO) said yesterday that it inked a definitive agreement to acquire RainDance Technologies for an undisclosed amount. The Hercules, Calif.-based company said it expects the transaction to close in the 1st quarter of 2017 and that it will reveal the terms of the acquisition when it discusses its 4th quarter and full-year financial […]

Filed Under: Diagnostics, Wall Street Beat Tagged With: Bio-Rad Laboratories, RainDance Technologies

Bio-Rad picks up cytometer platform from Propel

February 8, 2016 By Fink Densford

Bio-Rad Laboratories (NYSE:BIO) said today it acquired Propel Labs high performance analytical flow cytometer platform, with a planned instrument launch from the acquisition later this year. Flow cytometry is a technique used to identify and sort cells and their components, Hercules, Calif.-based Bio-Rad Laboratories said. “We welcome the opportunity to expand our relationship with Propel […]

Filed Under: Business/Financial News, Diagnostics, Mergers & Acquisitions, Regenerative Medicine Tagged With: Bio-Rad Laboratories, Propel Labs

Moody’s estimates med-tech tax impact

March 9, 2012 By MassDevice staff Leave a Comment

MassDevice.com med-tech tax coverage

The 2.3% tax on revenues slated to go into effect next year for medical device makers could top $650 million for the med-tech companies covered by Moody’s Investor Services, according to a report by the ratings agency.

The tax will help slow EBIDTA growth rates for the med-tech sector to between 1% and 4% over the next year to 18 months, according to Moody’s, with organic growth rates of between 2% and 3% during that period.

Filed Under: News Well, Wall Street Beat Tagged With: Baxter, becton dickinson, Bio-Rad Laboratories, Biomet, Boston Scientific, C.R. Bard, CareFusion Corp., Covidien, Dentsply Sirona, DJO Global, Hillrom, Hospira Inc., Immucor Inc., Kinetic Concepts Inc., stjudemedical, Stryker, Teleflex, Zimmer Biomet

NuVasive closes Impulse Monitoring deal | Acquisitions Roundup

October 12, 2011 By MassDevice staff Leave a Comment

NuVasive
Impulse Monitoring

NuVasive (NSDQ:NUVA) closed its $80 million pickup of Impulse Monitoring Inc. last week, according to a filing with the federal Securities & Exchange Commission.

The deal, which closed Oct. 7, saw IMI’s shareholders receive nearly $40.5 million in cash and more than 2.3 million shares of NuVasive common stock with an aggregate value of about $40.5 million (per NUVA’s Oct. 6 closing share price of $17.32).

Filed Under: Mergers & Acquisitions, News Well Tagged With: Acquisitions Roundup, AeroScout, Aptiv Solutions, Bio-Rad Laboratories, Boston Endo-Surgical, ConvaTec, cyberonics, Farmhurst Medical, Impulse Monitoring Inc., ImThera Medical Inc., LensAR Inc., Nuvasive, Precision Engineered Products, Quantalife, Sentient Health, SRA Global Clinical Development, Topcon, Trimline, Welch Allyn

  • Go to page 1
  • Go to page 2
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS